LATENT TUBERCULOSIS
Clinical trials for LATENT TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new LATENT TUBERCULOSIS trials appear
Sign up with your email to follow new studies for LATENT TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a 2-Month TB prevention be as good as 4 months?
Disease control CompletedThis study tested whether taking a higher dose of the drug rifampin for 2 months is as safe and effective as the standard 4-month dose for treating latent tuberculosis (TB) infection. Over 1,300 adults and children aged 10 and older with latent TB were randomly assigned to receiv…
Matched conditions: LATENT TUBERCULOSIS
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 23, 2026 11:55 UTC
-
New dosing study aims to protect kids from latent TB
Disease control CompletedThis study looked at how to best dose two medicines, rifapentine and isoniazid, for children aged 0-12 with latent (hidden) tuberculosis infection. The goal was to find a dose that works as well as in adults to prevent the infection from turning into active TB. The study included…
Matched conditions: LATENT TUBERCULOSIS
Phase: PHASE1, PHASE2 • Sponsor: Centers for Disease Control and Prevention • Aim: Disease control
Last updated Jun 22, 2026 12:08 UTC